Shanghai Kehua Bio-Engineering Co.,Ltd 002022.SZ Stock
Shanghai Kehua Bio-Engineering Co.,Ltd Price Chart
Shanghai Kehua Bio-Engineering Co.,Ltd 002022.SZ Financial and Trading Overview
Contents
Shanghai Kehua Bio-Engineering Co.,Ltd stock price | 7.19 CNY |
Previous Close | 10.2 CNY |
Open | 10.22 CNY |
Bid | 10.24 CNY x 0 |
Ask | 10.25 CNY x 0 |
Day's Range | 10.17 - 10.31 CNY |
52 Week Range | 7.92 - 14.42 CNY |
Volume | 2.57M CNY |
Avg. Volume | 5.59M CNY |
Market Cap | 5.27B CNY |
Beta (5Y Monthly) | 0.298287 |
PE Ratio (TTM) | 5.3664923 |
EPS (TTM) | -0.46 CNY |
Forward Dividend & Yield | 0.6 (6.03%) |
Ex-Dividend Date | May 10, 2023 |
1y Target Est | N/A |
002022.SZ Valuation Measures
Enterprise Value | 4.07B CNY |
Trailing P/E | 5.3664923 |
Forward P/E | 18.981482 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.71405965 |
Price/Book (mrq) | 1.0829371 |
Enterprise Value/Revenue | 0.552 |
Enterprise Value/EBITDA | 1.717 |
Trading Information
Shanghai Kehua Bio-Engineering Co.,Ltd Stock Price History
Beta (5Y Monthly) | 0.298287 |
52-Week Change | 18.32% |
S&P500 52-Week Change | 20.43% |
52 Week High | 14.42 CNY |
52 Week Low | 7.92 CNY |
50-Day Moving Average | 11.56 CNY |
200-Day Moving Average | 12.28 CNY |
002022.SZ Share Statistics
Avg. Volume (3 month) | 5.59M CNY |
Avg. Daily Volume (10-Days) | 3.67M CNY |
Shares Outstanding | 514.3M |
Float | 398.26M |
Short Ratio | N/A |
% Held by Insiders | 23.12% |
% Held by Institutions | 2.93% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.6 |
Trailing Annual Dividend Yield | 5.88% |
5 Year Average Dividend Yield | 83.00% |
Payout Ratio | 0.0345 |
Last Split Factor | 12:10 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 13.59% |
Operating Margin (ttm) | 29.80% |
Gross Margin | 51.06% |
EBITDA Margin | 32.12% |
Management Effectiveness
Return on Assets (ttm) | 20.66% |
Return on Equity (ttm) | 36.57% |
Income Statement
Revenue (ttm) | 7.38B CNY |
Revenue Per Share (ttm) | 14.36 CNY |
Quarterly Revenue Growth (yoy) | 98.09% |
Gross Profit (ttm) | N/A |
EBITDA | 2.37B CNY |
Net Income Avi to Common (ttm) | 1B CNY |
Diluted EPS (ttm) | 1.91 |
Quarterly Earnings Growth (yoy) | 145.79% |
Balance Sheet
Total Cash (mrq) | 2.82B CNY |
Total Cash Per Share (mrq) | 5.49 CNY |
Total Debt (mrq) | 893.96M CNY |
Total Debt/Equity (mrq) | 15.53 CNY |
Current Ratio (mrq) | 4.128 |
Book Value Per Share (mrq) | 9.465 |
Cash Flow Statement
Operating Cash Flow (ttm) | 1.73B CNY |
Levered Free Cash Flow (ttm) | 699.88M CNY |
Profile of Shanghai Kehua Bio-Engineering Co.,Ltd
Country | China |
State | N/A |
City | Shanghai |
Address | Caohejing Hi-Tech Park |
ZIP | 200233 |
Phone | 86 21 6485 0088 |
Website | https://www.skhb.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 2709 |
Shanghai Kehua Bio-Engineering Co.,Ltd researches and develops, produces, and sells in vitro diagnostic products in China. The company offers HBV, hepatitis B, HCV antibody, alpha fetoprotein quantitative, and fecal occult blood test kits; carcino-embryonic antigen quantitative determination kits; test kits for antibody to treponema pallidum and human immunodeficiency virus, and the five serological markers of hepatitis B; and diagnostic kit for syphilis rapid plasma regain. It also provides automatic biochemical analysis systems for clinical laboratories and medical institutions; nucleic acid blood screening systems; automatic chemiluminescence measuring systems; microplate readers and plate washers; general and dedicated reagent packaging systems; and electrolyte analyzers. In addition, the company researches and develops diagnostic products in the field of renal disease that provides screening diagnosis and therapeutic effect monitoring solutions for patients with various types of kidney disease. Further, it offers single-part and multi-part nucleic acid detection, and enzyme immunoassay analysis systems; reagents for blood collection agencies and clinical diagnosis; and laboratory diagnostic instruments. Additionally, the company distributes automatic chemiluminescence, microbial, and blood and urine analysis systems, as well as their supporting supplies; and automatic biochemical analyzers and other products. It also establishes third-party medical laboratory centers; provides planning and designing, management consulting, equipment and reagent supplying, and supply chain optimization services for medical laboratories, as well as medical testing services. In addition, the company is involved in the social medical undertakings. It also exports its Kehua-branded products to 38 countries and regions. The company was founded in 1981 and is based in Shanghai, the People's Republic of China.
Q&A For Shanghai Kehua Bio-Engineering Co.,Ltd Stock
What is a current 002022.SZ stock price?
Shanghai Kehua Bio-Engineering Co.,Ltd 002022.SZ stock price today per share is 7.19 CNY.
How to purchase Shanghai Kehua Bio-Engineering Co.,Ltd stock?
You can buy 002022.SZ shares on the Shenzhen exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Shanghai Kehua Bio-Engineering Co.,Ltd?
The stock symbol or ticker of Shanghai Kehua Bio-Engineering Co.,Ltd is 002022.SZ.
Which industry does the Shanghai Kehua Bio-Engineering Co.,Ltd company belong to?
The Shanghai Kehua Bio-Engineering Co.,Ltd industry is Medical Devices.
How many shares does Shanghai Kehua Bio-Engineering Co.,Ltd have in circulation?
The max supply of Shanghai Kehua Bio-Engineering Co.,Ltd shares is 514.32M.
What is Shanghai Kehua Bio-Engineering Co.,Ltd Price to Earnings Ratio (PE Ratio)?
Shanghai Kehua Bio-Engineering Co.,Ltd PE Ratio is now.
What was Shanghai Kehua Bio-Engineering Co.,Ltd earnings per share over the trailing 12 months (TTM)?
Shanghai Kehua Bio-Engineering Co.,Ltd EPS is -0.46 CNY over the trailing 12 months.
Which sector does the Shanghai Kehua Bio-Engineering Co.,Ltd company belong to?
The Shanghai Kehua Bio-Engineering Co.,Ltd sector is Healthcare.